# Nelarabine

NDC: 39822-0650
Generic name: Nelarabine
Labeler / Manufacturer: XGen Pharmaceuticals DJB, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20250217

FDA application: ANDA216510

## Active ingredients

- NELARABINE: 5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"39822-0650"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=39822-0650
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a1cc1580-50d9-4b9b-a002-1fc6686a9515